| Title |
The classification of fibromyalgia syndrome
|
|---|---|
| Published in |
Rheumatology International, July 2007
|
| DOI | 10.1007/s00296-007-0403-9 |
| Pubmed ID | |
| Authors |
W. Müller, E. M. Schneider, T. Stratz |
| Abstract |
As has been shown by a number of working groups, primary fibromyalgia syndrome does not represent a single clinical entity. It is possible to distinguish between a subgroup with high pain sensitivity and no associated psychiatric condition, a second and a third subgroup characterized by depression associated with fibromyalgia syndrome, and a fourth group with somatoform pain disorder of the fibromyalgia type. Mild inflammatory processes must be considered as the cause in the first group, while depression is combined with fibromyalgia in the second and the third group. In the fourth group, serious previous or still existing psychological problems or also insufficient coping with illness symptoms must be regarded as the reason for pain chronification. Group 1 benefits from a blocking of the 5-HT3 receptors by means of tropisetron, for example. This does not only affect pain chronification but also the inflammatory process itself. Group 2 and 3 needs antidepressant treatment, whereas the focus should be on psychotherapy in group 4. Groups 1, 2 and 3 will also profit from multimodal physical treatment programs, to a certain extent this applies to group 4 as well. So-called mixed types require a combination of therapeutic measures. |
Mendeley readers
The data shown below were compiled from readership statistics for 91 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 1% |
| Italy | 1 | 1% |
| Brazil | 1 | 1% |
| Unknown | 88 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 11 | 12% |
| Student > Bachelor | 11 | 12% |
| Student > Master | 9 | 10% |
| Student > Doctoral Student | 8 | 9% |
| Student > Postgraduate | 8 | 9% |
| Other | 21 | 23% |
| Unknown | 23 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 22 | 24% |
| Medicine and Dentistry | 18 | 20% |
| Nursing and Health Professions | 8 | 9% |
| Agricultural and Biological Sciences | 6 | 7% |
| Neuroscience | 3 | 3% |
| Other | 10 | 11% |
| Unknown | 24 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 January 2016.
All research outputs
#7,451,942
of 22,782,096 outputs
Outputs from Rheumatology International
#800
of 2,179 outputs
Outputs of similar age
#24,332
of 67,109 outputs
Outputs of similar age from Rheumatology International
#3
of 10 outputs
Altmetric has tracked 22,782,096 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,179 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 67,109 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 7 of them.